Lv2
190 积分 2025-04-16 加入
Real-world characteristics of trastuzumab deruxtecan-related interstitial lung disease in Japanese patients with breast cancer and gastric cancer
29天前
已完结
Neoadjuvant Anbenitamab and HB1801 in ERBB2 -Positive Breast Cancer
1个月前
已完结
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
1个月前
已完结
HER2-targeted therapies — a role beyond breast cancer
3个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
3个月前
已完结
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
4个月前
已完结
Black cohosh (Cimicifuga racemosa) for menopausal symptoms: A systematic review of its efficacy
4个月前
已完结
The effects of remifemin® on subjective symptoms of menopause
4个月前
已完结
Menopause
4个月前
已关闭
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
5个月前
已完结
皖公网安备34019202002308
